Roche's Rituxan Cures Rare Skin-Blistering Disease in Study Bloomberg “With one shot of rituximab we have a long-term result,” he said, using Rituxan's generic name. Rituxan, approved as a treatment for lymphoma, leukemia and rheumatoid arthritis, had sales of 6.7 billion Swiss francs ($7.1 billion) last year, making it ... |
